logo
  

Pre-market Movers: MFH, ESOA, COOK, FSRD, ALLG…

us pre market 053119 24mar22 lt

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.45 A.M. ET).

In the Green

Mercurity Fintech Holding Inc. (MFH) is up over 59% at $3.35
Energy Services of America Corporation (ESOA) is up over 40% at $4.62
Fast Radius, Inc. (FSRD) is up over 16% at $2.22
Allego N.V. (ALLG) is up over 15% at $20.50
OneSmart International Education Group Limited (ONE) is up over 11% at $1.97
Incannex Healthcare Limited (IXHL) is up over 9% at $12.88
PHX Minerals Inc. (PHX) is up over 9% at $3.12.
Cano Health, Inc. (CANO) is up over 6% at $7.01

In the Red

Traeger, Inc. (COOK) is down over 20% at $7.01
Hello Group Inc. (MOMO) is down over 8% at $6.83
Phunware, Inc. (PHUN) is down over 8% at $2.64
BridgeBio Pharma, Inc. (BBIO) is down over 7% at $10.00
FreightCar America, Inc. (RAIL) is down over 7% at $5.41
Apellis Pharmaceuticals, Inc. (APLS) is down over 6% at $49.49
AdTheorent Holding Company, Inc. (ADTH) is down over 6% at $7.20

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT